Form 4 for GILD Gilead Sciences

Accepted 2024-02-02 00:00:00 ET · period of report 2024-01-31 · accession 0001127602-24-003022 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2024-02-02	2024-01-31	GILD	Dickinson Andrew D	CFO	F - Tax	$78.26	-23.4K	129.4K	-15%	-$1.83M
M	2024-02-02	2024-01-31	GILD	Dickinson Andrew D	CFO	A - Grant	$0.00	+75.0K	152.8K	+96%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-01-31	F	D	23,410	$78.26	129,436	D	—	—
2	Common	Common Stock	2024-01-31	A	A	19,006	$0.00	96,891	D	—	—	(F1) Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2022 and March 10, 2023. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met.
3	Common	Common Stock	2024-01-31	A	A	55,955	$0.00	152,846	D	—	—	(F2) Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on March 10, 2021. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors.